SEC Form 4 · accession 0001576427-17-000104
Criteo S.A. · CRTO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dana L Evan
Director
Period of report
May 16, 2017
Accepted (ET)
May 18, 2017 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001576427
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2,F3 | May 16, 2017 | M | 3,866 | $44.82 | A | 3,866 | D | |
| Ordinary SharesF1,F4,F3 | May 16, 2017 | S | 3,866 | $51.94 | D | 0 | D | |
| Ordinary SharesF1,F5,F3 | May 16, 2017 | M | 10,300 | $10.54 | A | 10,300 | D | |
| Ordinary SharesF1,F4,F3 | May 16, 2017 | S | 10,300 | $51.94 | D | 0 | D | |
| Ordinary SharesF1,F5,F3 | May 17, 2017 | M | 10,000 | $10.54 | A | 10,000 | D | |
| Ordinary SharesF1,F6,F3 | May 17, 2017 | S | 10,000 | $44.60 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-employee Warrant (right to buy)F3,F2,F7,F1 | $44.82 | May 16, 2017 | M | 3,866 | D | — | Mar 19, 2025 | Ordinary Shares | 3,866 | 3,864 | D |
| Non-employee Warrant (right to buy)F3,F5,F7,F1 | $10.54 | May 16, 2017 | M | 10,300 | D | — | Mar 6, 2023 | Ordinary Shares | 10,300 | 10,300 | D |
| Non-employee Warrant (right to buy)F3,F5,F7,F1 | $10.54 | May 17, 2017 | M | 10,000 | D | — | Mar 6, 2023 | Ordinary Shares | 10,000 | 300 | D |
Explanation of responses
- F1The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- F2The exercise price of the non-employee warrant is 41.02 euros. The U.S. dollar equivalent of the exercise price is $44.82 using the Federal Reserve Bank of New York noon buying rate for May 12, 2017 (1.00 = $1.0926)
- F3For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC").
- F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.80 to $52.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote (6) to this Form 4.
- F5The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.54 using the Federal Reserve Bank of New York noon buying rate for May 12, 2017 (1.00 = $1.0926)
- F6The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.60 to $44.66, inclusive.
- F7One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter.